These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Britain opens biotech regulation to greater public involvement. Masood E Nature; 1999 May; 399(6734):287-8. PubMed ID: 10360555 [No Abstract] [Full Text] [Related]
12. The sanctity of life in a brave new world: a manifesto on biotechnology and human dignity. Council for Biotechnology Policy, USA Hum Reprod Genet Ethics; 2003; 9(2):36-7. PubMed ID: 14964213 [No Abstract] [Full Text] [Related]
14. Human gene patents: core issues in a multi-layered debate. Hoedemaekers R Med Health Care Philos; 2001; 4(2):211-21. PubMed ID: 11547507 [TBL] [Abstract][Full Text] [Related]
16. The Cambridge model: how public oversight of biotech is good for everyone--even business. Lipson S Genewatch; 2003; 16(5):7-10. PubMed ID: 15025120 [No Abstract] [Full Text] [Related]
17. How not to run a scientifically successful country. Nature; 1998 Apr; 392(6678):741. PubMed ID: 11645055 [No Abstract] [Full Text] [Related]
18. Making the world a better place: genes and ethics. Crisp R Sci Eng Ethics; 1995 Apr; 1(2):101-10. PubMed ID: 11660708 [No Abstract] [Full Text] [Related]
19. Bio-patents, law and ethics. Critical analysis of the EU biotechnology directive. Van Overwalle G Rev Derecho Genoma Hum; 2003; (19):187-203. PubMed ID: 15032104 [No Abstract] [Full Text] [Related]
20. Knowledge and the governance of biotechnology. Doubleday R Not Polit; 2001; 17(62):22-33. PubMed ID: 15468484 [No Abstract] [Full Text] [Related] [Next] [New Search]